Legend Biotech Corp reported a total revenue of $280.5 million for the six months ended June 30, 2024, significantly up from $109.7 million in the same period in 2023, with a net loss of $78 million for 2024 compared to a loss of $311 million in 2023. This filing was submitted on August 9, 2024, covering the company's performance and product pipeline updates.